6 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"depressive disorder, major depressive disorder, mood disorder, psychiatric disorderActive, not recruitingPhase 32026-09-28NCT06564818
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)depressive disorder, major depressive disorder, mood disorder, psychiatric disorderEnrolling by invitationPhase 32026-09-25NCT06605105
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's TypeDyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, nervous system disorderActive, not recruitingPhase 32026-09-15NCT05397639
An Open-Label Study of Azetukalner in Major Depressive Disorderdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderEnrolling by invitationPhase 32026-09-03NCT06922110
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorderdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderRecruitingPhase 32026-08-03NCT06775379
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorderActive, not recruitingPhase 32026-05-15NCT06564142